Lead Product(s) : Thymosin Beta-4
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Ora, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
Details : Thymosin beta 4 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 04, 2011
Lead Product(s) : Thymosin Beta-4
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Ora, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Thymosin Beta-4
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Thymosin beta 4 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Myocardial Infarction.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 09, 2011
Lead Product(s) : Thymosin Beta-4
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable